Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 19 Issue 9, September 2022

Inspired by the Clinical Outlook on p511.

Cover design: Patrick Morgan.

Clinical Outlook

  • Some chemotherapeutic agents can induce distinct mutational signatures in healthy cells in patients with cancer. The effect of such mutational signatures on spermatogenesis is not fully understood but is of great clinical importance for counselling patients diagnosed with cancer planning to start a family after treatment.

    • Ari P. Bernstein
    • Justin Loloi
    • Ranjith Ramasamy
    Clinical Outlook

    Advertisement

Top of page ⤴

Research Highlights

Top of page ⤴

Reviews

  • In this Review, the authors summarize current advances in our understanding of the roles of stroma and associated extracellular matrix during bladder cancer development, describing the bladder tumour microenvironment and introducing the concept of the metastatic tumour microenvironment.

    • Yu-Cheng Lee
    • Hung-Ming Lam
    • Keith Syson Chan
    Review Article
Top of page ⤴

Consensus Statement

  • The three-piece inflatable penile prosthesis offers an excellent treatment option for some men with erectile dysfunction, but implant surgery is not without surgical risks and can carry additional cosmetic and psychosocial consequences in poorly selected and consented individuals. In this Consensus Statement, an international group of key opinion leaders and high-volume prosthetic surgeons review the current guidelines and clinical evidence and present their expert consensus regarding patient selection, technique and complications of inflatable penile prosthesis surgery.

    • Eric Chung
    • Carlo Bettocchi
    • Gerald Brock
    Consensus Statement
Top of page ⤴

Perspectives

  • In this Review, the authors discuss racial differences in the prevalence of genetic mutations in the main molecular drivers of prostate cancer and provide input regarding the role of genomics in racial disparities observed in prostate cancer outcomes.

    • Camilo Arenas-Gallo
    • Jude Owiredu
    • Jonathan E. Shoag
    Perspective
Top of page ⤴

Search

Quick links